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Abstract. 
 
A critical role for the small GTPase Rho 
and one of its targets, p160ROCK (a Rho-associated 
coiled coil-forming protein kinase), in neurite remodel-
ing was examined in neuroblastoma N1E-115 cells. Us-
ing wild-type and a dominant-negative form of 
p160ROCK and a p160ROCK-specific inhibitor, Y-27632, 
we show here that p160ROCK activation is necessary 
and sufficient for the agonist-induced neurite retraction 
and cell rounding. The neurite retraction was accompa-
nied by elevated phosphorylation of myosin light chain 
and the disassembly of the intermediate filaments and 
microtubules. Y-27632 blocked both neurite retraction 
and the elevation of myosin light chain phosphorylation 
in a similar concentration-dependent manner. On the 
other hand, suppression of p160ROCK activity by ex-
pression of a dominant-negative form of p160ROCK 
induced neurites in the presence of serum by inducing 
the reassembly of the intermediate filaments and mi-
crotubules. The neurite outgrowth by the p160ROCK 
inhibition was blocked by coexpression of dominant-
negative forms of Cdc42 and Rac, indicating that 
p160ROCK constitutively and negatively regulates 
neurite formation at least in part by inhibiting activa-
tion of Cdc42 and Rac. The assembly of microtubules 
and intermediate filaments to form extended processes 
by inhibitors of the Rho–ROCK pathway was also ob-
served in Swiss 3T3 cells. These results indicate that 
Rho/ROCK-dependent tonic inhibition of cell process 
extension is exerted via activation of the actomysin-
based contractility, in conjunction with a suppression of 
assembly of intermediate filaments and microtubules in 
many cell types including, but not exclusive to, neu-
ronal cells.
 
A
 
xonal
 
 guidance is regulated by interaction of a
growth cone with various environmental cues. Ex-
tracellular signals critical in this process include
diffusible chemoattractants and chemorepellants, or vari-
ous kinds of extracellular matrix proteins and cell adhe-
sion molecules. Once the growth cone receives these sig-
nals, it moves either toward or away from them (for review
see Keynes and Cook, 1995). Such signal-induced motion
is, at least in part, mediated by protrusion and retraction
of the filopodia and lamellipodia present in the growth
cone. The shape and movement of these structures is pre-
sumably determined by the reorganization of the actin cy-
toskeleton (for review see Bently and O’Connor, 1994; Lin
et al., 1994; Tanaka and Sabry, 1995).
Rho family proteins including Rho, Rac, and Cdc42 par-
ticipate in the reorganization of actin cytoskeleton from
yeast to mammals (for review see Hall, 1994). In cultured
fibroblasts, Rho regulates the formation of focal adhesions
and stress fibers, whereas Rac and Cdc42 regulate the
growth factor–induced membrane ruffling and filopodia
formation, respectively (Ridley and Hall, 1992; Ridley et al.,
1992; Kozma et al., 1995; Nobes and Hall, 1995). Recently,
several lines of evidence suggested that Rho family pro-
teins play a critical role in axonal and dendritic outgrowth.
In 
 
Drosophila
 
 
 
melanogaster
 
, constitutively active and dom-
inant-negative Rac mutants both induced the disruption of
axon outgrowth (Luo et al
 
.
 
, 1994). Furthermore, axon ter-
minal formation was significantly reduced in Purkinje cells
of mice expressing a constitutively active form of Rac as a
transgene (Luo et al
 
.
 
, 1996). 
 
mig-2
 
 gene product, also a
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member of the Rho family proteins, was shown to be criti-
cal for cell migration and axon outgrowth in 
 
Caenorhabdi-
tis elegans 
 
(Zipkin et al., 1997). In vitro
 
, 
 
microinjection of
Cdc42 and Rac into cultured N1E-115 neuroblastoma
cells, respectively, induced filopodia and lamellipodia in
the growth cone (Kozma et al., 1997); these GTPases me-
diated the action of acetylcholine to induce these mem-
brane structures in this cell line. On the other hand, other
types of agonists such as lysophosphatidic acid (LPA),
 
1
 
thrombin, sphingosine-1-phosphate, or serum itself in-
duced rapid growth cone collapse and neurite retraction in
several cultured neuronal cell lines such as N1E-115 cells,
NG108-15 neuroblastoma-glioma hybrid cells, and PC12
pheochromocytoma cells (Jalink et al
 
.
 
, 1992, 1994; Postma
et al
 
.
 
, 1996; Tigyi et al., 1996
 
a
 
). This dramatic morphologi-
cal change was inhibited by pretreatment of the cells with
 
botulinum 
 
C3 exoenzyme, which inactivates Rho by ADP
ribosylation, indicating the involvement of Rho in this pro-
cess. Consistently, overexpression or microinjection of
constitutively active Rho into these cells induced growth
cone collapse and marked cell rounding (Kozma et al.,
1997; Kranenburg et al., 1997). These findings supported
the hypothesis that the Rho family GTPases mediated the
protrusion and the collapse of the growth cone and per-
haps regulated its motility. However, the intracellular sig-
naling mechanisms by which these GTPases exert their ac-
tions in the growth cone have remained unknown.
Recently, several putative target molecules of Rho were
isolated (for review see Narumiya et al
 
.
 
, 1997). Among
them, a family of Rho-associated serine/threonine kinase
isozymes named p160ROCK (Ishizaki et al., 1996) and
ROK
 
a
 
/Rho-kinase/ROCK-II (Leung et al., 1995; Matsui
et al., 1996; Nakagawa et al., 1996) has been identified as a
new class of Rho effectors, which induced focal adhesions
and stress fibers in cultured fibroblasts and epithelial cells
(Leung et al., 1996; Ishizaki et al., 1997; Amano et al.,
1997). Kimura et al. (1996) showed that Rho-kinase phos-
phorylated and inactivated myosin phosphatase in vitro
and suggested that it thereby regulated myosin light chain
(MLC) phosphorylation. We recently identified a new py-
ridine derivative named Y-27632 as a specific inhibitor of
the ROCK/ROK family of protein kinases (Uehata et al.,
1997). This compound inhibited smooth muscle contrac-
tion both in vitro and in vivo, as well as the formation of
stress fibers and focal adhesions induced by p160ROCK in
cultured cells. These findings suggested that ROCK medi-
ated the Rho effect on the formation of focal adhesions
and stress fibers, at least partly through the regulation of
actomyosin system.
In this study, we used Y-27632 and wild-type and a dom-
inant-negative form of p160ROCK, and examined the role
of p160ROCK in the neurite remodeling of N1E-115 cells.
Our findings indicate that p160ROCK not only mediates
the agonist-induced neurite retraction but also tonically
suppresses neurite outgrowth in the presence of serum.
The former action appears to be exerted through both the
activation of the actomyosin system and the disassembly
of the intermediate filaments and microtubules. The latter
suppression appears partly due to inactivation of Cdc42
and Rac, because the inhibition of the p160ROCK leads to
the activation of Cdc42 and Rac and to the neurite induc-
tion. Our findings further indicate that the opposing ac-
tions of p160ROCK on the actin cytoskeleton and the
other two types of cytoskeletons are not limited to the
cells of neuronal origin.
 
Materials and Methods
 
Materials
 
LPA was purchased from Sigma Chemical Co (St. Louis, MO). Rabbit
polyclonal anti-peripherin antibody, mouse monoclonal anti-vimentin an-
tibody (LN-6), and mouse monoclonal anti–
 
b
 
-tubulin antibody (N-357)
were purchased from Chemicon (Temecula, California), Sigma Chemical
Co., and Amersham (Little Chalfont, UK), respectively. Mouse mono-
clonal anti-FLAG M2 antibody was obtained from Eastman Kodak Co.
(New Haven, CT). pEXV-myc-V14RhoA and Swiss 3T3 cells were kindly
provided by A. Hall (University College London, London, UK). pCMV-
myc-N17Cdc42 and pCMV5-FLAG-N17Rac1 were provided by M. Sy-
mons (Onyx Pharmaceuticals, Richmond, CA) and Y. Kaziro (Tokyo In-
stitute of Technology, Tokyo, Japan). Y-27632 was supplied by Yoshitomi
Pharmaceutical Industries (Saitama, Japan). 
 
Botulinum
 
 C3 exoenzyme
was purified as described (Jalink et al., 1994). Rabbit polyclonal anti-
ROCK antibody 20490 and anti-myc antibody 9E10 were prepared as de-
scribed (Fujita et al., 1997; Ishizaki et al., 1997).
 
Assay for Neurite Retraction
 
Mouse neuroblastoma N1E-115 cells were maintained in DME supple-
mented with 10% FBS. For neurite induction, N1E-115 cells were cul-
tured in serum-free DME for 24 h. More than 90% of the cells became
flattened and extended neurites under these conditions. Neurite retraction
was evoked by incubating cells with 1 
 
m
 
M LPA for 10 min, with or without
preincubation with indicated concentrations of Y-27632 for 30 min. Phase-
contrast photomicrographs were taken before the Y-27632 pretreatment
and after the LPA stimulation. More than 200 cells were identified in ran-
domly chosen fields of view, and the percentage of cells that retracted
neurites after LPA application was calculated.
 
p160ROCK Expression Constructs and
Cell Transfection
 
Myc-tagged wild-type and dominant–negative mutant of p160ROCK
(KD-IA) were constructed in the pCAG mammalian expression vector as
previously described (Ishizaki et al., 1997) (see Fig. 1). N1E-115 cells were
plated at a density of 2 
 
3 
 
10
 
4
 
 cells per 3.5-cm dish and of 10
 
5
 
 cells per
3.5-cm dish for immunofluorescence and immunoblotting studies, respec-
tively. After culture for 1 d, cells were transfected with the plasmid DNA
(1 
 
m
 
g) by the application of lipofectamine-DNA coprecipitates in Opti-
MEM (Gibco Laboratories, Grand Island, NY) (Ishizaki et al., 1996). For
cotransfection of KD-IA with either N17Rac1 or N17Cdc42, 1 
 
m
 
g of each
plasmid DNA was used. For transfection with V14Rho, wild-type
p160ROCK, the medium was changed to serum-free DME at 4 h and then
the cells were cultured for another 12 h. For transfection with the KD-IA
mutant, the medium was replaced by DME containing 10% FBS at 4 h
and the cells were cultured for another 16 h in the presence of serum.
 
Immunofluorescent Staining of N1E-115 Cells and 
Swiss3T3 Cells
 
N1E-115 cells were cultured as described above. Swiss 3T3 cells were
plated on glass coverslips at a density of 3 
 
3 
 
10
 
4
 
 cells per 6-cm dish in
DME containing 10% FBS. Incubation of Swiss 3T3 cells with 30 
 
m
 
g/ml of
C3 exoenzyme for 72 h or with 10 
 
m
 
M Y-27632 for 2 h was carried out in
the presence of serum. Fixation, permeabilization, and blocking steps for
actin staining and immunofluorescence with anti-myc, anti-FLAG, anti-
ROCK, and anti-peripherin antibodies were performed as described
(Stokoe et al. 1994). For immunostaining with anti-vimentin and anti-
tubulin antibodies, cells were fixed with 3% paraformaldehyde in PBS
(
 
2
 
) at room temperature for 20 min, permeabilized with 0.2% Triton
 
1.
 
Abbreviations used in this paper
 
: GFAP, glial fibrillary acidic protein;
LPA, lysophosphatidic acid; MLC, myosin light chain; p160ROCK, p160
Rho-associated coiled coil-forming protein kinase. 
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X-100 in PBS (
 
2
 
), and then blocked with 1% BSA in PBS (
 
2
 
). N1E-115
cells were first incubated with primary antibodies in a Blotto solution (5%
skim milk, 0.1% Triton X-100, 0.1% Tween-20 in PBS[
 
2
 
]); anti-periph-
erin polyclonal antibody (1:200 in Blotto), anti-myc (9E10) monoclonal
antibody (1:300 in Blotto), anti-FLAG antibody (1:100 in Blotto), anti-
tubulin monoclonal antibody (1:100 in PBS containing 1% BSA) and anti-
p160ROCK polyclonal antibody (1:300 in Blotto). Anti-myc (9E10) and
anti-FLAG antibodies were detected with FITC-conjugated anti–mouse
IgG (Vector Laboratories, Burlingame, CA). Rhodamine-conjugated
anti–rabbit IgG (Vector Laboratories) was used to detect the signal of
anti-peripherin antibody. For F-actin staining, rhodamine-conjugated
phalloidin (Molecular Probes, Inc., Eugene, OR) was added after incuba-
tion with the second antibody. Anti-tubulin antibody and anti-p160ROCK
antibody were detected by rhodamine-conjugated anti–mouse IgM
(Kirkegaard & Perry Laboratories, Inc., Gaithersburg, MD) and FITC-
conjugated anti–rabbit IgG (Vector Laboratories), respectively. Swiss 3T3
cells were first incubated with either anti-vimentin antibody (1:100 in
Blotto) or anti-tubulin antibody (1:100 in Blotto). Anti-vimentin antibody
were detected with rhodamine-conjugated anti–mouse IgM. For F-actin
staining, OregonGreen-conjugated phalloidin (Molecular Probes, Inc.)
was added after incubation with the secondary antibody. Cells were ana-
lyzed at 0.36-
 
m
 
m optical sections on a laser scanning confocal microscope
imaging system (model MRC-1024; Bio-Rad Laboratories, Hercules, CA)
and built-up images were constructed.
 
Microinjection and Video Microscopy
 
Swiss 3T3 cells were plated on a glass coverslip at 3 
 
3 
 
10
 
4
 
 cells per 3.5-cm
dish and then cultured in DME containing 10% FBS for 24 h. Medium
was changed to Hepes-buffered DME containing 10% FBS and the cells
were incubated for 1 h. A coverslip was then transferred onto a heated
stage maintained at 37
 
8
 
C in the Hepes-buffered medium. C3 exoenzyme
at 150 
 
m
 
g/
 
m
 
l was injected into Swiss cells by the use of Eppendorf Microin-
jector 5242 (Eppendorf Scientific, Inc., Hamburg, Germany) as described
previously (Watanabe et al
 
.
 
, 1997). Time-lapse analysis was carried out by
phase contrast on an Axiovert microscope (model 100; Carl Zeiss, Inc.,
Thornwood, NY) with a Hamamatsu charge-coupled device camera
(model C2400; Hamamatsu Phototonics, Hamamatsu City, Japan) and re-
corded by a SONY laser video disc recorder (model LVR-3000AN; Sony
Corp., Park Ridge, NJ) Images were printed by a SONY color video
printer (model UP-1850).
 
Western Blotting Analysis of p160ROCK in
N1E-115 Cells
 
N1E-115 cells were lysed in
 
 
 
Laemmli’s SDS-PAGE sample buffer. The
cell lysates were subjected to SDS-PAGE on a 8% polyacrylamide gel,
and then separated proteins were transferred onto a nitrocellulose mem-
brane (BA85; Schleicher & Schuell, Inc., Keene, NH). The membrane was
blocked with 5% BSA in Tris-buffered saline. The membrane was probed
with anti-p160ROCK rabbit antibody 20490 (Fujita et al., 1997) and then
the signal was detected by alkaline phosphatase-conjugated anti–rabbit
IgG antibody (Kirkegaard & Perry Laboratories, Inc.).
 
Detection of MLC Phosphorylation
 
N1E-115 cells were allowed to extend neurites in serum-free DME and
were preincubated with or without various concentrations of Y-27632 for
30 min. The cells were then stimulated for indicated times with 1 
 
m
 
M LPA
and then lysed in Laemmli’s SDS-PAGE sample buffer. The cell lysates
were subjected to immunoblotting with anti-phosphorylated MLC (p-
MLC) rabbit antibody (Matsumura et al., 1998) using alkaline phos-
phatase staining system as described above.
 
Results
 
Y-27632 Inhibits Agonist-induced Neurite Retraction
 
Under serum starvation, most N1E-115 cells became flat-
tened and extended neurites with prominent growth cones
(Fig. 2, 
 
B
 
 and 
 
D
 
). As reported previously (Suidan et al.,
1992; Jalink et al., 1993), the addition of LPA to these cells
caused rapid collapse of growth cones and neurite retrac-
tion. This morphological change was usually complete
within 5 min, and in 10 min most cells became round and
few, if any, neurites remained extended (Fig. 2 
 
C
 
). We pre-
viously demonstrated that this neurite retraction was
blocked completely by a previous treatment of the cells
with C3 exoenzyme, indicating the involvement of Rho in
this process (Jalink et al., 1994).
To examine a role of p160ROCK in this Rho-mediated
neurite retraction, we first examined the presence of this
kinase in N1E-115 cells by Western blotting analysis. As
shown in Fig. 2 
 
A
 
, a single, positively stained band was
found at 160 kD, suggesting the presence of p160ROCK in
this cell line. We then applied a specific p160ROCK inhib-
itor, Y-27632, onto serum-starved, neurite-extended N1E-
115 cells before the LPA addition, and examined its effects
on the LPA-induced morphological change. As shown in
Fig. 2, 
 
D
 
 and 
 
E
 
, LPA-induced neurite retraction, as well as
cell rounding of N1E-115 cells, was completely abolished
by the treatment with 10 
 
m
 
M Y-27632. This inhibition oc-
curred in a concentration-dependent manner, with a 50%
inhibitory concentration (IC
 
50
 
) value of 0.56 
 
m
 
M (Fig. 3).
Y-27632 also inhibited neurite retraction induced by other
agonists such as serum and thrombin with similar IC
 
50
 
 val-
ues (data not shown). These results strongly indicated that
p160ROCK was necessary as a downstream effector of Rho
for the agonist-induced neurite retraction in N1E-115 cells.
 
Overexpression of p160ROCK Induces Marked 
Rounding of N1E-115 Cells
 
To confirm the involvement of p160ROCK in the neurite
retraction and to test whether p160ROCK activation was
sufficient for the above change of the N1E cell morphol-
ogy, we transiently overexpressed either V14Rho or the
wild-type p160ROCK in N1E-115 cells and examined the
morphology of the cells expressing the respective proteins.
After transfection, the cells were incubated in serum-free
DME for 12 h. Transfected cells were identified by stain-
ing the Myc epitope and F-actin organization was exam-
ined by phalloidin staining. In the serum-free medium,
nontransfected cells had flattened polygonal cell bodies
and extended neurites as above (Fig. 4). On the other
hand, cells expressing either V14Rho or the wild-type
p160ROCK showed a marked cell rounding. No extended
neurites were found in these cells, although very thin
spikes were observed on their periphery. In both transfec-
tants, strong actin staining was found under the plasma
Figure 1. Schematic representation of the wild-type and the KD-IA
mutant of p160ROCK. Domains of p160ROCK and the point
mutations in the KD-IA mutant are illustrated. KD, serine/threo-
nine protein kinase domain; CCD, coiled-coil forming am-
phiphatic a-helical domain; RBD, Rho-binding domain; PH,
pleckstrin homology domain; CRD, cysteine-rich zinc-finger do-
main; X, positions of mutations with amino acid numbers. 
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membrane of the round cell bodies. These experiments
clearly showed that activation of the Rho and ROCK
pathway is sufficient to block and to completely reverse
cell flattening and neurite extension seen in the serum-
starved state.
 
Expression of a Dominant-negative Mutant of 
p160ROCK and Treatment with Y-27632 Induces 
Neurites in N1E-115 Cells
 
The round cell morphology induced by p160ROCK is not
only similar to that evoked by the agonist-induced neurite
retraction in these cells as noted above, but also to that
elicited in the continued presence of serum. Because se-
rum can induce the activation of endogenous Rho in a va-
riety of cells (Hall, 1994), these findings suggest that the
round cell morphology in the presence of serum is medi-
ated by the Rho–ROCK pathway. However, it does not
necessarily indicate that inactivation of the Rho–ROCK
pathway is sufficient to induce neurite extension in these
cells. We therefore transfected N1E-115 cells with the KD-IA
mutant of p160ROCK, and cultured them in the presence
of serum. This mutant has point mutations both in the ki-
nase domain and the Rho-binding domain, and is defective
in both kinase activity and Rho binding. Our previous
study in HeLa cells had established that this mutant inhib-
its endogenous p160ROCK activity by a dominant-nega-
tive mechanism (Ishizaki et al., 1997). As shown in Fig. 5
 
A
 
, cells expressing KD-IA mutant extended long neurites
in a culture medium containing 10% FBS. We next incu-
bated N1E-115 cells with Y-27632 in the presence of se-
rum and followed their morphology. As shown in Fig. 5 
 
B
 
,
the cells became polygonal and extended neurites in a
time-dependent manner. Thus, the presence of serum
makes p160ROCK constitutively active to prevent neurite
formation and inactivation of this activity is sufficient for
neurite extension. Notably, the cell bodies of the trans-
fected or treated cells were not fully flattened, indicating
that the phenotype induced by ROCK inhibition in the
presence of serum may not be exactly identical to that in-
duced by serum starvation. This phenotype of N1E-115
cells is reminiscent of that induced by treatment of C3 exo-
enzyme in the same cells as well as other neuronal cells
such as PC-12 cells (Nishiki et al., 1990; Jalink et al., 1994).
These results indicate that pathways other than the Rho–
ROCK pathway are also activated by serum and may be
responsible for the cell rounding found in these cells in the
presence of serum.
Recently, Kozma et al. (1997) reported that the C3 ex-
oenzyme-induced neurite outgrowth is inhibited by micro-
injection of dominant-negative forms of Cdc42 and Rac,
and suggested that inhibition of the Rho pathway leads to
activation of either one or both of the Cdc42 and Rac
pathways, which in turn by themselves could induce neu-
rite outgrowth. They further showed that neurite exten-
sion induced by serum starvation was also blocked by
expression of dominant-negative Cdc42 and Rac. We,
Figure 2. Western blotting of p160ROCK in N1E-115 cells (A)
and inhibition of LPA-induced neurite retraction and cell round-
ing by Y-27632 (B–E). (A) N1E-115 cells were lysed in Laemmli–
SDS-PAGE sample buffer and then subjected to immunoblotting
using anti-p160ROCK antibody. (B–E), N1E-115 cells were
maintained in serum-free DME for 24 h and allowed to extend
neurites. The cells were pretreated without (B and C) or with 10
mM Y-27632 (D and E) for 30 min, and exposed to 1 mM LPA for
10 min. The same fields were photographed before the drug addi-
tion (Band D) and after LPA stimulation (C and E). Bar, 100 mm.
Figure 3. Concentration-dependent inhibition by Y-27632 of
LPA-induced neurite retraction in N1E-115 cells. Serum-starved
N1E-115 cells were pretreated with the indicated concentrations
of Y-27632 for 30 min and then exposed to 1 mM LPA for 10 min.
The percentages of cells with complete neurite retraction are
shown. Results of three experiments are shown as mean 6 SEM. 
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therefore, examined if activation of Cdc42 and Rac was
also involved in the expression of the KD-IA phenotype.
As shown in Fig. 6, expression of N17Cdc42 and N17Rac
inhibited the neurite generation induced by expression of
the KD-IA mutant in N1E-115 cells.
 
p160ROCK Induces MLC Phosphorylation during 
Agonist-induced Neurite Retraction
 
Having established the causal relationship between activa-
 
tion of the Rho–ROCK pathway and the agonist-induced
neurite retraction and cell rounding of N1E-115 cells, we
next examined whether p160ROCK provided a mechanis-
tic link leading to an increase in the actomyosin-driven
contractility, as suggested in our previous study (Jalink et al.,
1994). First, using an anti-phospho-MLC antibody which
specifically recognized MLC phosphorylated at Ser19
(Matsumura et al., 1998), we examined whether MLC
phosphorylation was elevated in N1E-115 cells during
neurite retraction. As shown in Fig. 7 
 
A
 
, the immunoblot-
ting analysis using the above antibody revealed a transient
increase in phospho-MLC content in response to LPA ap-
plied to serum-starved N1E-115 cells. The MLC phosphor-
ylation peaked at 1–2 min and gradually declined thereaf-
ter, but the phosphorylation level still remained high at 30
min. This time course was consistent with the rapidity and
the stability of the morphological changes induced by LPA.
We then asked if this stimulus-evoked MLC phosphoryla-
tion was mediated by p160ROCK. The serum-starved cells
were pretreated with various concentrations of Y-27632
for 30 min and were then stimulated by 1 
 
m
 
M LPA. Effects
on MLC phosphorylation was examined at 2 min after the
LPA addition. Y-27632 inhibited the increase of MLC
phosphorylation in a concentration-dependent manner;
the inhibition was evident at 1 
 
m
 
M and complete at 10 
 
m
 
M
(Fig. 7 
 
B
 
). On the other hand, the total amount of MLC
did not change in these samples (data not shown). This
concentration–effect relationship was quite similar to that
seen for inhibition of the LPA-induced neurite retraction
and cell rounding (refer to Fig. 3). These results provide
compelling evidence for a role of p160ROCK in the regu-
lation of the growth cone contractility via MLC phosphor-
ylation. Whether this is elicited through a Ca
 
2
 
1
 
-sensitiza-
tion mechanism similar to that found in smooth muscle
contraction (Uehata et al., 1997) remains to be established.
 
Effects of p160ROCK Activation and Inhibition on 
Assemblies of Intermediate Filaments and Microtubules 
in N1E-115 Cells
 
The above findings obtained by the pharmacological and
molecular biological manipulations of p160ROCK activity
Figure 4. Morphology of N1E-115 cells express-
ing active Rho and p160ROCK. N1E-115 cells
were transfected with V14Rho (A and B) or
wild-type p160ROCK (C and D), and were cul-
tured in serum-free DME for 12 h. Overexpress-
ing cells were identified by the positive Myc-
staining (A and C) and their F-actin structures
were examined (B and D). Note that the trans-
fected cells do not extend neurites even under
serum-starved conditions. In addition, marked
bleb formation was also noted in some of
p160ROCK-expressing cells. Bar, 20 mm.
Figure 5. Morphology of N1E-115 cells expressing the KD-IA
mutant and of N1E-115 cells treated with Y-27632. (A) N1E-115
cells were transfected with the KD-IA mutant, a dominant-nega-
tive form of p160ROCK, and were cultured for 16 h in the pres-
ence of 10% FBS. The cells were double-stained for the Myc-tag
(a) and F-actin (b). Note that the transfected cells extend long
neurites in the presence of serum. (B) N1E-115 cells were cul-
tured in the presence of 10% FBS, and treated with 10 mM Y-27632,
a specific ROCK inhibitor. Phase-contrast photomicrographs
were taken at 0 (a) and 60 min (b) after the addition of the com-
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strongly suggested that the agonist-induced neurite retrac-
tion and, to some extent, cell rounding was mediated by
p160ROCK at least partly through generation of the acto-
myosin-driven contractility. Our data also suggest that the
neurite outgrowth in N1E-115 cells might be tonically sup-
pressed by the Rho–p160ROCK pathway activated in the
presence of serum, and could be reinitiated by inhibiting
this pathway. Because neuritic processes are known to
contain specifically organized intermediate filaments and
microtubules as major cytoskeletons in addition to the ac-
tin microfilaments, we wondered whether the activation
and inhibition of p160ROCK could respectively induce
disassemblies and assemblies of the intermediate filaments
and microtubules in the neurite-like processes, in parallel
to the regulation of the actin cytoskeleton characterized
above. To address this point, we stained the serum-starved
neurite-extending cells, the serum-induced round cells,
and the cells expressing the KD-IA mutant of p160ROCK
with anti-peripherin and anti-tubulin antibodies. In the se-
rum-starved cells, peripherin, a major intermediate fila-
ment in N1E-115 cells, was well organized into a network
in the flattened cell bodies and part of it extended into the
neurites as thick bundles (Fig. 8). The peripherin cytoskel-
eton became disorganized and collapsed into a swirled
form in the round cells in the presence of serum (Fig. 8 B).
In contrast, a marked staining for peripherin which origi-
nated from the cell bodies and extended into the base of
the growth cones was present in the neurites even in the
presence of serum when KD-IA was expressed (Fig. 8 C).
Similarly, serum-dependent disorganization and ROCK
inhibition-induced reassembly was observed for microtu-
bule organization. Strong tubulin staining was found in
neurites of the cells expressing KD-IA (Fig. 8 F), whereas
it formed a fine network in serum-starved cells (Fig. 8 D)
and dismantled in the presence of serum (Fig. 8 E). These
results clearly showed that p160ROCK is critically in-
Figure 6. Inhibition by N17Cdc42 and N17Rac of the neurite
generation induced by the KD-IA mutant of p160ROCK. N1E-
115 cells were transfected with KD-IA p160ROCK alone (A and
B), with N17Cdc42 and KD-IA p160ROCK (C and D) or with
N17Rac and KD-IA p160ROCK (E and F). The transfected cells
were cultured in DME containing 10% FBS for 16 h. Overex-
pressing cells were identified with p160ROCK staining (A, C, and
E) and F-actin was stained with phalloidin (B, D, and F). Bar, 20
mm. (G) Quantification of cells bearing no neurites, short neu-
rites, and long neurites. N1E cells expressing KD-IA alone, KD-IA
and N17Cdc42, or KD-IA and N17Rac were identified as above,
and the numbers of cells bearing no neurites, or neurites shorter
or longer than 100 mm were determined. *, P , 0.001 compared
with KD-IA.
Figure 7. LPA-induced MLC phosphorylation and its inhibition
by Y-27632 in N1E-115 cells. (A) Time course of LPA-induced
MLC phosphorylation. Serum straved N1E-115 cells were incu-
bated with 1 mM LPA for the indicated times. Cells were col-
lected in Laemmli-SDS-PAGE sample buffer and then subjected
to immunoblotting using anti-phosphoMLC antibody. (B) Con-
centration-dependent inhibition of MLC phosphorylation by
Y-27632. Serum-starved N1E-115 cells were treated with the indi-
cated concentrations of Y-27632 for 30 min, and then stimulated
with LPA for 2 min. The cells were lysed and analyzed as above.
The content of MLC in the cells did not change during LPA stim-
ulation or Y-27632 treatment.Hirose et al. Neurite Remodeling Regulated by p160ROCK 1631
volved in the activity-dependent disassembly and reorga-
nization of the intermediate filaments and microtubules in
the neurites of N1E-115 cells, and suggested that inhibi-
tion of p160ROCK might be necessary to promote the as-
semblies of the two neuritic cytoskeletons.
Inhibition of p160ROCK Is Sufficient to Induce 
Neurite-like Processes in Swiss 3T3 Cells by Promoting 
Assemblies of Microtubules and
Intermediate Filaments
Since inhibition of p160ROCK led to the assemblies of the
intermediate filaments and microtubules in neuritic pro-
cesses, we next asked if this mechanism operated in mor-
phological remodeling of other types of cells. To address
this question, we used Swiss 3T3 cells, a naive system
which does not form neurite-like processes under normal
culture conditions. Inactivation of Rho by botulinum C3
exoenzyme in Swiss 3T3 cells caused round cell bodies
with long thin beaded processes (for examples see Figs. 10
E and 11 E). These processes have often been regarded as
retraction fibers, although they extend over the original
size of cells in many cases. To address this issue, we moni-
tored the morphology of Swiss cells injected with C3
exoenzyme by video microscopy. As shown in Fig. 9, cell
processes generated by C3 exoenzyme treatment changed
their morphology in time and some of them actively elon-
gated, indicating that new organization of cytoskeletons is
responsible for this process generation. Because these pro-
cesses morphologically resembled neurites of neuronal
cells, we reasoned that a mechanism analogous to the neu-
rite outgrowth in N1E-115 cells might be implicated in the
control of cell shapes in Swiss 3T3 cells. Indeed, treatment
with Y-27632 for more than 2 h induced the C3-like mor-
phological phenotype in Swiss 3T3 cells even in the pres-
ence of serum, although the morphological phenotype was
much weaker with shorter processes bearing less branch-
ing (Figs. 10 G and 11 G). Actin stress fibers disappeared
in these cells, confirming the complete loss of the ROCK
activity (Fig. 10, E and G and Fig. 11, E and G). Swiss 3T3
cells were then subjected to staining for tubulin and vi-
mentin, a major intermediate filament in these cells. Sharp
and strong staining of vimentin and tubulin were observed
in the processes of both C3 exoenzyme- and Y-27632–
treated cells (Fig. 10, F and H and Fig, 11 F and H). Fur-
thermore, similar cell morphology and patterns of vimentin
and tubulin staining were observed in the serum-starved
cells as well, though to a smaller extent (Fig. 10, C and D
and Fig. 11, C and D). These results indicate the intriguing
possibility that inhibition of the Rho–ROCK pathway per
se may be sufficient to initiate the rearrangement of mi-
crotubules and intermediate filaments required to trigger
new process formation in nonneuronal cells such as in
Swiss 3T3 cells, thus suggesting that a common mechanism
may govern the reorganization of different cytoskeletons
in neuronal cells and fibroblasts. Elucidation of the molec-
ular mechanism linking p160ROCK and the reorganiza-
tion of intermediate filaments and microtubules awaits
further studies.
Discussion
p160ROCK Mediates Agonist-induced
Neurite Retraction through Increase in
Actomyosin-based Contractility
The neuronal cell line N1E-115 is well known to become
flattened and to extend neurites upon serum starvation.
They also retract neurites and become round in response
to agonists including serum and LPA. A role for the small
GTPase Rho was suggested by many studies including
ours. However, the downstream effector molecule involved
in this Rho-mediated process has remained elusive. Here
we investigated the possibility that the ROCK/ROK family
of protein serine/threonine kinases including p160ROCK
Figure 8. Peripherin and tu-
bulin staining of serum-
starved, serum-fed, and KD-
IA–transfected N1E-115 cells.
N1E-115 cells were cultured
in the absence (A and D) or
presence (B and E) of serum,
or were transfected with the
KD-IA mutant of p160ROCK
and cultured in DME con-
taining 10% serum (C and
F). The cells were stained
with either anti-peripherin
(A,  B, and C) or anti-tubulin
(D, E, and F) antibodies. In
C and F, the cells were also
stained with either anti-myc
antibody (C), or anti-ROCK
antibody (F), and the cells
expressing KD-IA protein
were identified (indicated by
arrows). Images built from
optical sections by a confo-
cal imaging system are shown.
Bar, 20 mm.The Journal of Cell Biology, Volume 141, 1998 1632
and its isozyme, ROKa/Rho-kinase/ROCK-II, may be one
of the critical Rho effectors. In this study we have demon-
strated that Y-27632, a specific inhibitor of these kinases
competitive for their ATP-binding site (Uehata et al.,
1997), inhibited neurite retraction induced by LPA and
thrombin. The concentration dependency of the compound
for inhibition of the neurite retraction was similar to that
previously determined for the inhibition of agonist-induced
smooth muscle contraction by this compound, and was
consistent with its inhibitory potency on p160ROCK. Fur-
thermore, we have found that the overexpression of wild-
type p160ROCK evoked marked cell rounding even under
the serum-starved conditions, whereas the expression of
the KD-IA mutant, a dominant-negative form of p160ROCK,
completely abolished neurite retraction induced by serum
and induced new neurites in these cells. These results
strongly suggest that p160ROCK acts downstream of Rho
and that its kinase activity is necessary and sufficient to
mediate the agonist-induced neurite retraction in N1E-115
cells. Recently, a similar neurite-retracting activity of ROKa
was shown in PC-12 pheochromocytoma cells (Katoh et
al., 1998).
Our previous study (Jalink et al., 1994) indicated the
generation of tension along the neurites in N1E-115 cells
exposed to LPA. In this study, we have shown that LPA
application increased the level of phosphorylated MLC,
with a time course overlapping with that of the LPA-induced
morphological changes. Furthermore, Y-27632 inhibited
both the phosphorylation and morphological changes with
a similar dose-response relationship. Since MLC phosphor-
ylation is a critical step in generating an actomyosin-based
contractile force, our results suggest an essential role for
p160ROCK in triggering a Rho-dependent contraction in
N1E-115 cells, thus presumably leading to neurite retrac-
tion.
The contraction of the actomyosin system in smooth
muscle and nonmuscle cells is thought to be regulated by
two mechanisms: (a) one is dependent on increase in free
Ca21 ion in the cell and is mediated by MLC kinase and
(b) the other is a Ca21 sensitization mechanism. Several
lines of evidence now indicate a role for the ROCK/ROK
kinase family in the latter mechanism. Kimura et al. (1996)
Figure 9. Video-microscopy of Swiss 3T3 fibroblast microin-
jected with C3 exoenzyme. Swiss cells were maintained on a glass
coverslip in Hepes-buffered DME containing 10% FBS and mi-
croinjected with C3 exoenzyme. Morphology of the injected cells
was monitored by time-lapse video-microscopy. Four images
taken every two min are shown. Time after the injection is indi-
cated in the top left corner of each image. Note cell processes
change in their morphology in a time-dependent manner; arrow-
head, time-dependent elongation of one process. Bar, 20 mm.
Figure 10. Vimentin staining of Swiss 3T3 cells. Swiss 3T3 cells
were cultured in the presence (A and B) or absence (C and D) of
serum, or with 30 mg/ml C3 exoenzyme for 72 h (E and F) or 10 mM
Y-27632 for 2 h (G and H) in the presence of serum, and were
stained with OregonGreen phalloidin (A, C, E, and G) or with
anti-vimentin antibody (B, D, F, and H). Images built up from op-
tical sections by a confocal imaging system are shown. Bar, 20 mm.Hirose et al. Neurite Remodeling Regulated by p160ROCK 1633
reported that Rho-kinase phosphorylates the myosin bind-
ing subunit of myosin phosphatase in vitro and thereby in-
hibits its activity. Amano et al. (1996) further suggested
the possibility that Rho-kinase may also directly phosphor-
ylate MLC. Finally, Uehata et al. (1997) demonstrated
that Y-27632, which blocks the ROCK/ROK kinases in
vitro, inhibited smooth muscle contraction in vivo by spe-
cifically acting on the Ca21-sensitization mechanism. Our
present work extends these findings and provides a com-
mon basis for establishing an essential role for p160ROCK
in catalyzing the Rho-dependent regulation of actomy-
sion-based contractility, in neuronal as well as in nonneu-
ronal cell types.
The Rho–ROCK Pathway Regulates Reorganization of 
the Microtubules and the Intermediate Filaments
It is well known that the intermediate filaments and the
microtubules play important roles in the formation of neu-
rites or similar processes. Microtubule depolymerizating
drugs can cause neurite collapse in many types of cultured
neuronal cells (Daniels, 1975; Solomon and Magendantz,
1981; Joshi et al., 1985). In PC-12 cells, exposure to tubulin
mRNA antisense oligonucleotides led to tubulin depletion
and inhibition of neurite outgrowth (Teichman-Weinberg
et al., 1988). As for the intermediate filaments, a similar
antisense mRNA strategy was used to demonstrate the re-
quirement for glial fibrillary acidic protein (GFAP) in the
formation of stable processes in human astrocytoma cells
(Weinstein et al., 1991).
The present study has demonstrated that in N1E-115
cells, inhibition of ROCK in the presence of serum, by
overexpressing a dominant-negative form of p160ROCK,
generated an outgrowth of neuritic processes, which were
filled with thick fibers immunopositive for tubulin and pe-
ripherin (refer to Fig. 8). We also showed that in Swiss 3T3
cells, treatments with C3 exoenzyme or Y-27632, by them-
selves, induced extension of long neurite-like processes,
positively stained for structures containing both tubulin
and vimentin, a predominant intermediate filament in this
cell type. These results suggest that the ROCK/ROK pro-
tein kinase family may be critically involved in the regu-
lated reorganization of the intermediate filaments and the
microtubules, not only in neuronal but also in nonneu-
ronal cells. Our findings are consistent with Paterson et al.
(1990) who showed that the microinjection of V14Rho
caused the collapse of the vimentin structure in Swiss 3T3
cells. Thus, the morphological phenotypes and signal
transduction pathways regulated by p160ROCK may be
quite similar in neuronal cells such as N1E-115 cells and
nonneuronal cells such as Swiss 3T3 cells. However, the ul-
timate morphology of two types of cells appears different;
marked cell rounding in neuronal cells and flattened cell
bodies with stress fibers in nonneuronal cells. This is likely
due to the difference in the integrin-based focal adhesions
of these cells. How p160ROCK is involved in the differen-
tial regulation of these structures in the two types of cells
remains to be investigated.
At present, we do not know whether the ROCK effect
on intermediate filaments is a direct or indirect conse-
quence of phosphorylation events mediated by ROCK/
ROK kinases. Phosphorylation of the intermediate fila-
ments has been shown to be required for their interaction
with other cytoskeletal components and has been impli-
cated in neurite extension and functions (Nixon et al.,
1987; Aletta et al., 1989). Kosako et al. (1997) reported
that Rho-kinase, an isozyme of p160ROCK, phosphory-
lated a specific residue in GFAP, that had been previously
associated with the disassembly of the GFAP filaments
during cytokinesis in astrocytes. Thus, it is possible that ac-
tivated p160ROCK directly phosphorylates different types
of intermediate filament proteins, even in the cell types
that we examined, namely N1E-115 and Swiss 3T3 cells.
Our preliminary analysis, however, did not detect en-
hanced phosphorylation of peripherin after LPA stimula-
tion of N1E-115 cells, although we could not exclude the
possibility that residual p160ROCK activity could phos-
phorylate a specific residue of this protein (Hirose, M., T.
Ishizaki, and S. Narumiya, unpublished observations). On
the other hand, the disassembly of intermediate filaments
Figure 11. Tubulin staining of Swiss 3T3 cells. Swiss 3T3 cells
were cultured in the presence (A and B) or absence (C and D) of
serum, or with C3 exoenzyme (E and F) or Y-27632 (G and H) in
the presence of serum, and were stained with OregonGreen phal-
loidin (A, C, E, and G) or with anti-tubulin antibody (B, D, F,
and H). Images built from optical sections by a confocal imaging
system are shown. Bar, 20 mm.The Journal of Cell Biology, Volume 141, 1998 1634
as well as microtubules may well be a secondary conse-
quence of the regulation of the actomyosin system, in
which the tension generated by the ROCK-induced in-
crease in the myosin-based contractility may generate a yet
unknown secondary negative signaling event, which then
acts on the cytoskeletons and leads to their disruption. As
discussed below, many lines of evidence suggest that a pos-
itive regulation of the neurite outgrowth triggered by inac-
tivation of Rho may be exerted by other members of the
Rho family GTPases, such as Cdc42 and Rac. Thus, Rho-
dependent regulation of the assembly and disassembly of
the intermediate filaments might in fact be controlled via a
reciprocal activation/inactivation processes between Rho
and Cdc42/Rac.
The present study has also shown that activation and in-
activation of p160ROCK regulates the disassembly and as-
sembly of the microtubules. Previous reports demon-
strated that microtubule-depolymerizing agents induced
stress fiber formation in a C3 exoenzyme-sensitive man-
ner, thereby suggesting a signaling pathway from disrup-
tion of microtubules to Rho (Danowski et al., 1989; Eno-
moto, 1996; Zhang et al. 1997). However, no pathway from
Rho to the microtubules has been indicated. Our study
represents the first formal demonstration of a significant
role for a Rho-associated molecule, p160ROCK, in this
process. The parallelism in the p160ROCK-dependence
seen in both intermediate filaments and microtubules indi-
cate that Rho may simultaneously regulate the assembly
and disassembly of both cytoskeletal components through
a similar mechanism. In any event, the present study raises
an interesting possibility that the regulatory role of Rho
GTPases on the cytoskeleton may extend to the reorgani-
zation of the intermediate filaments and microtubules, in
addition to the well-known roles in actin cytoskeleton.
Current efforts in our laboratories are directed towards
the identification of the ROCK substrates implicated dur-
ing neurite retraction process, in order to sort out the dis-
tinct signaling pathways involved in these multiple regula-
tory processes.
Signaling Pathways in Neurite Remodeling: Interaction 
of the Rho–ROCK Pathway with Other Pathways
The present study has demonstrated a critical role for the
Rho-ROCK pathway not only in the agonist-induced neu-
rite retraction, but also in the tonic inhibition of neurite
outgrowth in N1E-115 cells in the presence of serum. Sup-
pression of this inhibitory pathway releases the cells from
their constraint and enables them to sprout and extend
new neurites. This role of the Rho–ROCK pathway as a
tonic negative regulator in cell process formation appears
not to be limited to N1E-115 cells, because previous stud-
ies demonstrated that inactivation of Rho by botulinum
C3 exoenzyme could also induce long neurites in PC12
cells (Nishiki et al., 1990; Tigyi et al., 1996a) as well as in
neuroblastoma NG108-15 cells (Moolenaar, 1994). Kozma
et al. (1997) found that this apparently stimulatory effect
of C3 exoenzyme on neurite outgrowth in N1E-115 cells
could be inhibited by expressing dominant-negative forms
of Cdc42 and Rac. Conversely, activation of Cdc42 and
Rac stimulated neurite outgrowth by inducing filopodia
and lamellipodia in the growth cones. Furthermore, coin-
jection of Rho with Cdc42 blocked the Cdc42-induced for-
mation of filopodia, suggesting that Rho signaling down-
regulates Cdc42 signaling in N1E-115 cells in a dominant
fashion (Kozma et al., 1997). Similarly, the overexpression
of the guanine nucleotide exchange factor for Rac, Tiam1,
induced neurite-like processes, which could be antago-
nized by expression of constitutively active Rho (van
Leeuwen et al., 1997). Taken together, these findings indi-
cate that p160ROCK, as a downstream effector of Rho,
may negatively regulate the Cdc42 and Rac pathway, both
of which play a positive role in growth cone expansion.
Consistent with this idea, we found that expression of
N17Cdc42 and N17Rac, dominant-negative forms of Cdc42
and Rac respectively, prevented the neurite growth induced
by the dominant-negative form of p160ROCK (refer to
Fig. 6).
In addition to these signaling cross-talks at the GTPases
level, functional interaction between different kinase path-
ways may also have to be considered. It has been known
for some time that activation of the cAMP pathway in-
duces neurite outgrowth in various neuronal cells includ-
ing PC12 cells (for example see Gunning et al., 1981). Re-
cently, Tigyi et al. (1996b) has reported that LPA-induced
neurite retraction is inhibited by the elevation of cAMP
levels in PC12 cells. This effect was not seen in a mutant
PC-12 clone deficient in protein kinase A. These results
suggest that the Rho–ROCK pathway may be antagonized
Figure 12. Model of signal transduction and cross-talks of the
Rho–ROCK pathway in the neurite remodeling. p160ROCK is
activated downstream of Rho in response to agonist stimulation,
and in turn induces the actomyosin-based contractility and the
disassembly of the microtubules and the intermediate filaments,
leading to the neurite retraction. p160ROCK also transmits a
negative signal to the Cdc42/Rac pathways and suppresses the
neurite outgrowth by tonically inhibiting their actions. The acti-
vation of the cAMP–A kinase pathway is likely to inhibit the
Rho–ROCK pathway and to release the suppression of neurite
outgrowth. Disassembly of intermediate filaments may be caused
by direct phosphorylation by p160ROCK at specific amino acid
residue(s) of this cytoskeletal proteins as shown for GFAP (Ko-
sako et al., 1997) or may well be a secondary consequence of
ROCK’s effect on the actomyosin system.Hirose et al. Neurite Remodeling Regulated by p160ROCK 1635
by the cAMP signaling pathway during ligand-induced
neurite remodelling and that inhibition of neurite retrac-
tion by cAMP may be exerted by an A kinase–dependent
inhibition of the Rho–ROCK pathway. Whether the cyclic
AMP-PKA effect acts on Rho, ROCK, a ROCK substrate,
or further downstream remains to be determined. The
possible interaction of these signaling pathways is depicted
in Fig 12.
In summary, the present study has demonstrated that
Rho-dependent p160ROCK activation is not only neces-
sary but also sufficient in mediating the agonist-induced
neurite retraction in N1E-115 cells. This study also demon-
strated that activation of the Rho–ROCK pathway exerts
tonic inhibition of neurite sprouting. How this signaling
pathway is regulated by physiological cues during axonal
pathfinding remains to be elucidated.
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Note Added in Proof. An independent report also suggested an involve-
ment of Rho-kinase–mediated MLC phosphorylation in LPA-induced
neurite retraction in N1E-115 cells. (Amano, M., K. Chihara, N. Naka-
mura, Y. Fukata, T. Yano, M. Shibata, M. Ikebe, and K. Kaibuchi. 1998.
Genes Cells 3:177–188).
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